Details about Márta Péntek

Access statistics for papers by Márta Péntek.

Last updated 2016-07-04. Update your information in the RePEc Author Service.

Short-id: ppn5

Working Papers

2015

1. The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?
   Corvinus Economics Working Papers (CEWP), Corvinus University of Budapest View citations (1)
   See also Journal Article The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?, Society and Economy, Akadémiai Kiadó, Hungary (2015) View citations (1) (2015)
2. Trading between perceived risks and benefits related to biosimilar biological treatment in Crohn’s disease; discrete choice experiment among gastroenterologists
   Corvinus Economics Working Papers (CEWP), Corvinus University of Budapest

Journal Articles

2016

1. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe
   The European Journal of Health Economics, 2016, 17, (1), 19-29 View citations (17)
2. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe
   The European Journal of Health Economics, 2016, 17, (1), 7-18 View citations (16)
3. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe
   The European Journal of Health Economics, 2016, 17, (1), 67-78 View citations (14)
4. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe
   The European Journal of Health Economics, 2016, 17, (1), 79-87 View citations (14)
5. Social/economic costs and health-related quality of life in patients with scleroderma in Europe
   The European Journal of Health Economics, 2016, 17, (1), 109-117 View citations (16)
6. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe
   The European Journal of Health Economics, 2016, 17, (1), 89-98 View citations (5)

2015

7. The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?
   Society and Economy, 2015, 37, (1), 73-88 View citations (1)
   See also Working Paper The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?, Corvinus Economics Working Papers (CEWP) (2015) View citations (1) (2015)

2014

8. Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective
   The European Journal of Health Economics, 2014, 15, (1), 73-82 View citations (5)
9. Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries
   The European Journal of Health Economics, 2014, 15, (1), 35-43 View citations (7)
10. Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries
    The European Journal of Health Economics, 2014, 15, (1), 65-71
11. Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis
    The European Journal of Health Economics, 2014, 15, (1), 45-52
12. Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison
    The European Journal of Health Economics, 2014, 15, (1), 53-64 View citations (2)
13. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
    The European Journal of Health Economics, 2014, 15, (1), 111-119 View citations (2)
14. HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain
    The European Journal of Health Economics, 2014, 15, (7), 675-680
15. Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists
    The European Journal of Health Economics, 2014, 15, (1), 83-92 View citations (2)
16. Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
    The European Journal of Health Economics, 2014, 15, (1), 27-34 View citations (2)

2012

17. Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study
    Health Policy, 2012, 108, (1), 19-26 View citations (6)
18. Health economics and health technology assessment in Central and Eastern Europe: a dose of reality
    The European Journal of Health Economics, 2012, 13, (5), 525-531 View citations (11)

2010

19. The disease burden of colorectal cancer in Hungary
    The European Journal of Health Economics, 2010, 10, (1), 35-40 View citations (2)

2003

20. Establishing a standard for patient-completed instrument adaptations in Eastern Europe: experience with the Nottingham Health Profile in Hungary
    Health Policy, 2003, 63, (1), 49-61